Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
Conditions
- Photosensitivity Disorders
Interventions
- DRUG: Diclofenac
- DRUG: Diclofenac
Sponsor
University Hospital Tuebingen